GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 72 days ( 11.27 % )
Last Price $0.91 0.556 %
High/ Low $0.89 - $0.97 25.98%
Chg 7 Days 18.46 % $0.764 $0.91
Chg 30 Days 123.40 % $0.405 $0.91
Chg 12 mos 293.48 % $0.230 $0.91
Trend - 3 mos 0.93 % Width: 140.89 %
Trend - 12 mos 66.89 % Width: 691.51 %
Pred. range - 3 mos $0.407 - $0.98 -55.00 % - 8.40 %
Pred. range - 12 mos $0.411 - $3.25 -54.62 % - 259.21 %
Short MA avg 3 mos Buy 2022-12-28 - 21 days
Long MA avg 3 mos Buy 2023-01-04 - 17 days
Short/Long MA avg 3 mos Buy 2023-01-10 - 13 days
Short MA avg 12 mos Buy 2022-12-30 - 19 days
Long MA avg 12 mos Buy 2023-01-20 - 6 days
Short/Long MA avg 12 mos Sell 2022-10-26 - 64 days
Pivot Short Buy 2023-01-25 - 3 days
Bollinger Sell 0000-00-00 - N/A days
MACD Buy No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Synthetics Biologics Inc

Synthetics Biologics Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), ... SYN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT